Clinical trial
Virtual-reality Induced Immune Modulation in Allergic Patients
NCT07721233 is registered in ClinicalTrials.gov with University of Geneva, Switzerland as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Virtual-reality Induced Immune Modulation in Allergic Patients
- Lead sponsor
- University of Geneva, Switzerland
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- November 1, 2026
- Completion date
- October 31, 2030
- Enrollment
- 81 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
hymenoptera venom allergy